Navigation Links
Americord Registry Becomes First Cord Blood Bank to Offer Placenta Preservation, Advancing Cord Blood Stem Cell Therapy Options
Date:10/19/2010

NEW YORK, Oct. 19 /PRNewswire/ -- Americord Registry announced its breakthrough placenta stem cell preservation process, the first of its kind, as a new and significantly more effective alternative to private cord blood stem cell banking. The new process, called Cord Plus, preserves up to ten times more stem cells from the placenta than is found on average in a unit of cord blood, which contains only enough stem cells to treat a patient weighing less than 65 pounds. As a result of this breakthrough, doctors may soon be able to cure substantially more people of sickle cell, leukemia, and other life threatening blood disorders.

Despite being the fastest growing stem cell therapy used therapeutically, "Cord blood has never developed into a practical treatment for adults because there are simply not enough stem cells in one unit of cord blood to transplant to an adult," said Children's Hospital & Research Center Oakland (Calif.) scientist Frans Kuypers, Ph.D., a leader in the area of placenta research. "The greater supply of stem cells in the placenta will likely increase the chance that an HLA (human leukocyte antigen) matched unit of stem cells engrafts, making stem cell transplants available to more people. The more stem cells, the bigger the chance of success," says Kuypers.

Stem cells harvested from cord blood, first introduced as a therapy in 1983, have been playing an important and growing role in the treatment of life-threatening blood diseases as an alternative to bone marrow stem cell treatment. The National Marrow Donor Program projects that there will be 10,000 cord blood transplants per year by 2015, up from 2,000 in 2006. Reasons for using cord blood and placenta derived stem cells over bone marrow include (i) it is more easily matched with a recipient, (ii) it is more readily available and (iii) there is a lower chance
'/>"/>

SOURCE Americord Registry
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMarin Announces Roll-Out of National PKU Registry
2. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries
3. Interim Analysis of Data from e-HEALING Registry of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) to be Presented at AHA Scientific Sessions 2008
4. EMD Serono Launches Landmark Patient Registry for Egg Freezing
5. CAS Registers 40 Millionth Substance in CAS REGISTRY(SM)
6. my1HIE(sm) Implements WellCentive Registry
7. InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry. InspireMD Will Also Sponsor a Satellite Program Breakfast Meeting at the TCT Conference on September 24th 2009 in the Moscone Exhibition Center in San Francisco
8. Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the Worlds First Adaptive 128-slice CT Scanner
9. MD Anderson Becomes a GeneGo Center of Excellence Using MetaCore for Oncology Research
10. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in PubMeds Peer-Reviewed Video Journal JoVE
11. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in Peer-Reviewed Video Journal JoVE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... , June 18, 2013 ... investment research firm, announces the initiation of ... French biopharmaceutical company developing and marketing products ... indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... report examining the investment merits of BioAlliance ...
(Date:6/18/2013)... ZIONA, Israel , June 18, ... of complex bulk Active Pharmaceutical Ingredients (APIs), generic and innovative ... systems, announced today that the company has been granted a ... is indicated in the US and Europe ... US Patent number 8,410,176 B2 is titled Intermediate ...
(Date:6/18/2013)... 18, 2013 Research ... the addition of the report " DNA ... to their offering.      (Logo: ... basics of human genome variations, development of ... and small sequencers are described as well ...
(Date:6/18/2013)... Scottsdale, AZ (PRWEB) June 18, 2013 ... telemedicine services MeMD, Inc proudly announces the release ... Revolutionizing Health and Fitness ". , MeMD's goal ... the ever-changing landscape of Health 2.0, Health 3.0 ... that will likely transform medical care and the ...
Breaking Biology Technology:Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2
... Sept. 18 /PRNewswire-FirstCall/-- Biodel Inc. (Nasdaq:,BIOD) today ... program,at the 43rd Scientific Sessions of the ... VIAject(TM) Phase II meal study data ... entitled, "Pharmacokinetics and pharmacodynamics of,insulin VIAject(TM), insulin ...
... Advantage of ... after HIV Infection, RICHMOND, Calif., Sept. 18 /PRNewswire-FirstCall/ ... the presentation of data,demonstrating that human CD4 T-cells can ... zinc finger DNA-binding protein nucleases,(ZFN(TM)) and preferentially survive and ...
... the Increasing Global Need for Genzyme Products, CAMBRIDGE, ... today broke ground on a significant expansion of its,flagship ... project is focused on adding space for manufacturing support,functions, ... The expansion was marked by a ceremony featuring ...
Cached Biology Technology:Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting 2Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting 3Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 2Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 3Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 4Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic 5Genzyme Begins Major Expansion of Boston Manufacturing Facility 2Genzyme Begins Major Expansion of Boston Manufacturing Facility 3Genzyme Begins Major Expansion of Boston Manufacturing Facility 4Genzyme Begins Major Expansion of Boston Manufacturing Facility 5
(Date:6/18/2013)... of DNA and this modification can occur in ... now, scientists believed that this epigenetic phenomenon actively ... team of researchers from the University of Geneva ... at the Faculty of Medicine, reveals that this ... methylation may play both a passive and active ...
(Date:6/18/2013)... of Adelaide shows that weight gain and increased head size ... a higher IQ at early school age. , The study was ... from more than 13,800 children who were born full-term. , The ... that babies who put on 40% of their birthweight in the ... time they were six years of age, compared with babies who ...
(Date:6/17/2013)... with central nervous system infections may well be suffering ... to a study to be published in mBio ... for Microbiology. Researchers have detected the virus in spinal ... nervous system infections of unknown cause, and in an ... and poultry, suggesting animals may serve as reservoirs for ...
Breaking Biology News(10 mins):The secret of DNA methylation 2IQ link to baby's weight gain in first month 2New virus discovered in patients with central nervous system infections 2New virus discovered in patients with central nervous system infections 3
... more than 10 years of cooperative research on ... the USDA Forest Service,s Pacific Southwest Research Station ... Phytophthora ramorum : A Summary of the Literature." ... of topics, including a history of sudden oak ...
... Vegas, NV (Dec. 24, 2010) - Three weeks of ... heart attack returned microRNA activity close to their pre-event ... studied, just six were attributed to exerting the majority ... study four microRNA optimally regulated by Longevinex and ...
... An expert working group of the International ... Clinical Chemistry and Laboratory Medicine (IFCC) has released ... of bone turnover markers (BTMs) in fracture risk ... it identifies research priorities and recommends that specific ...
Cached Biology News:Comprehensive report on sudden oak death 2Longevinex exerts greater influence over genes than resveratrol 2Longevinex exerts greater influence over genes than resveratrol 3Standardized protocols would greatly enhance clinical and research potential of BTMs 2
... Immunogen KLH-conjugated, synthetic ... 47-66 (PAEV-GPGAVGERTPRKKEPP) of human BRAF-HDAC ... (BHC110/LSD1). Quality Assurance ... Stability 2 years ...
Request Info...
...
...
Biology Products: